What is the Fiscal Year for BridgeBio?
Date: November 13, 2026
BridgeBio's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Palo Alto, California
Industry
Biotechnology Research
Stock Symbol
BBIO
Website
http://www.bridgebio.comDescription
We exist to bring transformative medicines to people living with genetic conditions. Our model pairs advances in genetic science with an entrepreneurial mindset, enabling us to move with urgency and translate scientific possibility into real-world impact. We’re building leaders as well as transformative medicines, and we’re looking for people driven to push boundaries, solve hard problems, and help patients who can’t wait any longer.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like BridgeBio and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.